Success Metrics

Clinical Success Rate

71.4%

Based on 5 completed trials

Completion Rate

71%(5/7)

Active Trials

0(0%)

Results Posted

80%(4 trials)

Terminated

2(18%)

Phase Distribution

Ph phase_2

Ph not_applicable

27%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Other(4)

Detailed Status

Completed5

unknown4

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

unknown436%

terminated218%

completed545%

Recent Activity

0 active trials

Showing 5 of 11

completed

Clinical Trials (11)

Showing 11 of 11 trials

NCT06060925

Imaging Biomarkers for Myofascial Pain

Completed

NCT01544335

Evaluation of BIS for Quantification of Lymphedema

Completed

NCT04606511Not Applicable

Lymphedema Screening

Unknown

NCT02764073

Bioimpedance Spectroscopy for the Evaluation of Heart Failure

Completed

NCT04451356

Romanian Kidney Transplant Cardiovascular Risk Registry

Unknown

NCT03372512

Fluid Status and T1-mapping by CMR

Unknown

NCT03237429

The Relationship Between BCM, Arterial Stiffness and Hemodynamic Instability During Induction of General Anesthesia

Unknown

NCT03648983Not Applicable

Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer

Terminated

NCT02325856Not Applicable

Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients

Completed

NCT01276054Phase 2

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

Terminated

NCT00769821

The Impact of Lymphedema on Breast Cancer Survivors

Completed

All 11 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 11